This Biotech Is Developing a Stem Cell Therapy for Deafness
Sheffield is one of the UK’s historic industrial bases. It also hosts the biotech Rinri…
11/10/2019 - 3 minutes
Cell therapy
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
27/09/2019 - 3 minutes
Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy
The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back…
11/09/2019 - 2 minutes
Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer
The Italian biotech Genenta Science has raised €13.2M in a private round to fund two…
11/09/2019 - 3 minutes
4BIO Capital Raises €45M Fund to Invest in Advanced Therapies
The London-based life sciences investor 4BIO Capital has raised €45M in the first close of…
09/09/2019 - 3 minutes
UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell…
03/09/2019 - 2 minutes
Off-the-Shelf Kidney Cancer Immunotherapy More Than Doubles Recovery in Phase II
An off-the-shelf cancer immunotherapy developed by the Swedish biotech Immunicum has eradicated kidney tumors in…
29/08/2019 - 3 minutes
Celgene and Immatics Sign Deal Worth Over €1.35B to Develop Cancer Immunotherapies
The US company Celgene has obtained options to three cancer immunotherapy programs from the German…
28/08/2019 - 3 minutes
Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once
A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of…
15/08/2019 - 3 minutes
Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
12/08/2019 - 2 minutes
The Future of Diabetes Treatment: Is a Cure Possible?
Diabetes has become an epidemic, sentencing over 422 million people worldwide to lifelong medication. Science…
15/07/2019 - 10 minutes
Approval Status of Cancer Cell Therapy at Risk After Halting Phase III Trial
Following an unfavorable interim analysis, Milan-based MolMed has suspended a phase III trial of its…
01/07/2019 - 2 minutes
